CapsoVision (CV) Operating Expenses (2024 - 2026)
CapsoVision (CV) posted Operating Expenses of $9.4 million for Q4 2025, down 5.18% sequentially from $9.9 million in Q3 2025, and up 47.9% YoY from $6.4 million in Q4 2024.
CapsoVision (CV) Operating Expenses (2024 - 2026) Analysis & Trends
CapsoVision has reported Operating Expenses for 2 years, with the latest figure at $9.4 million in Q4 2025.
- Quarterly Operating Expenses rose 47.9% year-over-year to $9.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $32.2 million (changed N/A YoY) and the FY2025 annual result came in at $32.7 million, up 24.32% from the prior year.
- Operating Expenses slipped to $9.4 million in Q4 2025 per CV's latest filing, from $9.9 million in the prior quarter.
- Over five years, Operating Expenses peaked at $9.9 million in Q3 2025 and troughed at $6.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 10.90 Bn |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn | 2.84 Bn |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn | 2.67 Bn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | 846.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 511.70 Mn |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn | 1.44 Bn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | -741.59 Mn |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | 398.30 Mn |
| 10 | CapsoVision | 295.63 Mn | 286.55 Mn | 1.87 Mn | 9.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.45 Mn |
| Dec 31, 2025 | 9.42 Mn |
| Sep 30, 2025 | 9.93 Mn |
| Jun 30, 2025 | 6.46 Mn |
| Dec 31, 2024 | 6.37 Mn |
| Sep 30, 2024 | 7.46 Mn |
| Jun 30, 2024 | 6.86 Mn |